ANJAC Well being & Magnificence Strengthens Its Presence in North America and Its Pharmaceutical Actions with the Acquisition of Pillar5 Pharma

PARIS, March 14, 2022–(BUSINESS WIRE)–At the moment ANJAC Well being & Magnificence (ANJAC) introduced its acquisition of Pillar5 Pharma (Pillar5), one of many main producers (CDMOs) specializing within the manufacturing of sterile ophthalmic options and area of interest stable dose manufacturing (tablets, capsules and so forth.). The acquisition reinforces ANJAC’s worldwide growth and broadens its well being choices with new ophthalmic providers for native and worldwide manufacturers and laboratories. That is ANJAC’s second main operation of 2022, following its acquisition of Apollo Healthcare in January.

Pillar5, a key CDMO stakeholder within the North American sterile ophthalmology market

Pillar5, a Canadian firm, is among the main North American CDMOs for the manufacturing of sterile ophthalmic options and stable dose manufacturing (tablets, capsules, and so forth.). Pillar5 is a trailblazer, the primary CDMO to supply multi-dose preservative free capabilities, an revolutionary ophthalmic resolution, on the North American market.

Pillar5, primarily based in Arnprior, Ontario, turned an unbiased firm in 2009, providing a full line of providers starting from formulation, product manufacturing and customized packaging to offering technical providers. Pillar5 has constructed a diversified portfolio of loyal purchasers, working with main pharmaceutical laboratories in addition to specialists in ophthalmological care.

The corporate has 150 staff, and a turnover of CAD$50M.

The expansion of ANJAC Well being & Magnificence continues with a singular entrepreneurial momentum

ANJAC’s settlement with Pillar5 marks its ninth acquisition in 5 years, which is able to carry its world turnover near 650 million euros. The group’s turnover could have doubled within the house of three years. Every new acquisition represents a possibility for ANJAC to develop its providers in particular domains and profit from their complementarities. The ANJAC group now contains 14 specialised corporations, with 22 R&D and manufacturing websites.

We’re more than happy with this strategic acquisition. It’ll foster our progress in a brand new key sector, the ophthalmology market, particularly by sterile, multi-dose preservative free ophthalmic options, an innovation with excessive added worth,” says Aurélien Chaufour, President of ANJAC.

“We’re delighted to affix a family-owned industrial group that may help our bold growth initiatives. We’re already figuring out synergies, significantly on a business degree, with worldwide purchasers that might be a great match for Pillar5 and different corporations within the ANJAC group,” says Dwight Gorham, President and CEO of Pillar5.

About ANJAC Well being & Magnificence
ANJAC Well being & Magnificence is a French family-owned industrial group and a companion to magnificence & wellness manufacturers and pharmaceutical laboratories. It creates, develops and manufactures, from uncooked supplies to the completed product. ANJAC is made up of the next 14 specialised and complementary corporations, with 22 R&D and manufacturing websites within the fields of well being, magnificence, private care and meals dietary supplements: Aircos, Apollo, Chemineau, Cosmetix West, Euro Wipes, Feltor, Innovi, LPEV, Pascual Cosmétiques, Pillar5, Roval Cosmétiques, Shadeline and Sicaf. Based in 2008, the group now has a workforce of over 3,000 and a consolidated turnover near €650 million.

For extra info:

About Pillar5
Based in 2009, Pillar5 Pharma is an industry-leading Canadian CDMO with sturdy capabilities in sterile ophthalmic manufacturing. We’re presently the one CDMO with the power to fabricate multi-dose preservative free (MDPF) options for the North American market. Our award-winning manufacturing facility was constructed by Pfizer in 1956 and has been instrumental to our firm’s continued progress and success.

For info:


Lillentech and Mazars (monetary providers), and each Fasken Martineau DuMoulin LLP and Gibson Dunn & Crutcher LLP (authorized providers), have acted as consultants for ANJAC.
Bloom Burton (monetary) and Norton Rose LLP (authorized) had been consultants for Pillar5.

View supply model on


Nicolas Fuseau – [email protected] – +33 6 59 42 29 35

Previous post Martha Stewart CBD Expands Taste Portfolio With Launch of New Tropical Medley CBD Wellness Gummies
Next post Regenerative Medication Market to Garner $83.19 Bn, Globally, by 2030 at 23.4% CAGR: Allied Market Analysis | Information